HIV infection and arterial inflammation assessed by 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET): A prospective cross-sectional study

Andreas Knudsen; Anne Mette Fisker Hag; Annika Loft; Eric von Benzon; Sune H Keller; Holger Jon Møller; Anne-Mette Lebech; Rasmus Sejersten Ripa; Andreas Kjær

doi:10.1007/s12350-014-0032-0

HIV infection and arterial inflammation assessed by ¹⁸F-fluorodeoxyglucose (FDG) positron emission tomography (PET): A prospective cross-sectional study

Andreas Knudsen, Anne Mette Fisker Hag, Annika Loft, Eric von Benzon, Sune H Keller, Holger Jon Møller, Anne-Mette Lebech, Rasmus Sejersten Ripa, Andreas Kjær

Endocrinology and Metabolism

15 Citationer (Scopus)

Abstract

BACKGROUND: HIV-infected patients are at increased risk of myocardial infarction and arterial inflammation has been suggested as a pathophysiological explanation. We compared the uptake of (18)F-fluorodeoxyglucose (FDG) by PET in four arterial regions, and factors associated with FDG uptake in well-treated HIV-infected patients without cardiovascular disease (CVD) and healthy controls.

METHODS AND RESULTS: We prospectively scanned 26 HIV-infected patients on stable antiretroviral therapy and 25 healthy volunteers with FDG PET/CT, measuring standardized uptake values (SUV) in the carotid arteries, the ascending, descending, and abdominal aorta. We performed correlation analyses between FDG uptake and intima-media thickness (IMT), and soluble biomarkers of inflammation. We found no difference in arterial FDG uptake between the HIV-infected patients and healthy controls quantified either as mean SUVmax or target-to background ratio in the carotid region, the ascending aorta, the descending aorta, or the abdominal aorta. Correlations between SUV, IMT, and soluble biomarkers were scarce in both groups.

CONCLUSION: In a group of optimally treated HIV-infected patients with full viral suppression, low Framingham risk score and no known CVD, we found no evidence of increased arterial inflammation as assessed by FDG PET/CT compared to healthy volunteers.

Originalsprog	Engelsk
Tidsskrift	Journal of Nuclear Cardiology
Vol/bind	22
Udgave nummer	2
Sider (fra-til)	372-80
Antal sider	9
ISSN	1071-3581
DOI	https://doi.org/10.1007/s12350-014-0032-0
Status	Udgivet - 10 mar. 2015

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

10.1007/s12350-014-0032-0

Citationsformater

Knudsen, A., Hag, A. M. F., Loft, A., von Benzon, E., Keller, S. H., Møller, H. J., Lebech, A-M., Ripa, R. S., & Kjær, A. (2015). HIV infection and arterial inflammation assessed by ¹⁸F-fluorodeoxyglucose (FDG) positron emission tomography (PET): A prospective cross-sectional study. Journal of Nuclear Cardiology, 22(2), 372-80. https://doi.org/10.1007/s12350-014-0032-0

HIV infection and arterial inflammation assessed by ¹⁸F-fluorodeoxyglucose (FDG) positron emission tomography (PET) : A prospective cross-sectional study. / Knudsen, Andreas; Hag, Anne Mette Fisker; Loft, Annika et al.

I: Journal of Nuclear Cardiology, Bind 22, Nr. 2, 10.03.2015, s. 372-80.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

@article{3aa357692d644820b5a9b64818d3c56f,

title = "HIV infection and arterial inflammation assessed by 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET): A prospective cross-sectional study",

abstract = "BACKGROUND: HIV-infected patients are at increased risk of myocardial infarction and arterial inflammation has been suggested as a pathophysiological explanation. We compared the uptake of (18)F-fluorodeoxyglucose (FDG) by PET in four arterial regions, and factors associated with FDG uptake in well-treated HIV-infected patients without cardiovascular disease (CVD) and healthy controls.METHODS AND RESULTS: We prospectively scanned 26 HIV-infected patients on stable antiretroviral therapy and 25 healthy volunteers with FDG PET/CT, measuring standardized uptake values (SUV) in the carotid arteries, the ascending, descending, and abdominal aorta. We performed correlation analyses between FDG uptake and intima-media thickness (IMT), and soluble biomarkers of inflammation. We found no difference in arterial FDG uptake between the HIV-infected patients and healthy controls quantified either as mean SUVmax or target-to background ratio in the carotid region, the ascending aorta, the descending aorta, or the abdominal aorta. Correlations between SUV, IMT, and soluble biomarkers were scarce in both groups.CONCLUSION: In a group of optimally treated HIV-infected patients with full viral suppression, low Framingham risk score and no known CVD, we found no evidence of increased arterial inflammation as assessed by FDG PET/CT compared to healthy volunteers.",

author = "Andreas Knudsen and Hag, {Anne Mette Fisker} and Annika Loft and {von Benzon}, Eric and Keller, {Sune H} and M{\o}ller, {Holger Jon} and Anne-Mette Lebech and Ripa, {Rasmus Sejersten} and Andreas Kj{\ae}r",

year = "2015",

month = mar,

day = "10",

doi = "10.1007/s12350-014-0032-0",

language = "English",

volume = "22",

pages = "372--80",

journal = "Journal of Nuclear Cardiology",

issn = "1071-3581",

publisher = "Springer",

number = "2",

}

TY - JOUR

T1 - HIV infection and arterial inflammation assessed by 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)

T2 - A prospective cross-sectional study

AU - Knudsen, Andreas

AU - Hag, Anne Mette Fisker

AU - Loft, Annika

AU - von Benzon, Eric

AU - Keller, Sune H

AU - Møller, Holger Jon

AU - Lebech, Anne-Mette

AU - Ripa, Rasmus Sejersten

AU - Kjær, Andreas

PY - 2015/3/10

Y1 - 2015/3/10

N2 - BACKGROUND: HIV-infected patients are at increased risk of myocardial infarction and arterial inflammation has been suggested as a pathophysiological explanation. We compared the uptake of (18)F-fluorodeoxyglucose (FDG) by PET in four arterial regions, and factors associated with FDG uptake in well-treated HIV-infected patients without cardiovascular disease (CVD) and healthy controls.METHODS AND RESULTS: We prospectively scanned 26 HIV-infected patients on stable antiretroviral therapy and 25 healthy volunteers with FDG PET/CT, measuring standardized uptake values (SUV) in the carotid arteries, the ascending, descending, and abdominal aorta. We performed correlation analyses between FDG uptake and intima-media thickness (IMT), and soluble biomarkers of inflammation. We found no difference in arterial FDG uptake between the HIV-infected patients and healthy controls quantified either as mean SUVmax or target-to background ratio in the carotid region, the ascending aorta, the descending aorta, or the abdominal aorta. Correlations between SUV, IMT, and soluble biomarkers were scarce in both groups.CONCLUSION: In a group of optimally treated HIV-infected patients with full viral suppression, low Framingham risk score and no known CVD, we found no evidence of increased arterial inflammation as assessed by FDG PET/CT compared to healthy volunteers.

AB - BACKGROUND: HIV-infected patients are at increased risk of myocardial infarction and arterial inflammation has been suggested as a pathophysiological explanation. We compared the uptake of (18)F-fluorodeoxyglucose (FDG) by PET in four arterial regions, and factors associated with FDG uptake in well-treated HIV-infected patients without cardiovascular disease (CVD) and healthy controls.METHODS AND RESULTS: We prospectively scanned 26 HIV-infected patients on stable antiretroviral therapy and 25 healthy volunteers with FDG PET/CT, measuring standardized uptake values (SUV) in the carotid arteries, the ascending, descending, and abdominal aorta. We performed correlation analyses between FDG uptake and intima-media thickness (IMT), and soluble biomarkers of inflammation. We found no difference in arterial FDG uptake between the HIV-infected patients and healthy controls quantified either as mean SUVmax or target-to background ratio in the carotid region, the ascending aorta, the descending aorta, or the abdominal aorta. Correlations between SUV, IMT, and soluble biomarkers were scarce in both groups.CONCLUSION: In a group of optimally treated HIV-infected patients with full viral suppression, low Framingham risk score and no known CVD, we found no evidence of increased arterial inflammation as assessed by FDG PET/CT compared to healthy volunteers.

U2 - 10.1007/s12350-014-0032-0

DO - 10.1007/s12350-014-0032-0

M3 - Journal article

C2 - 25467249

SN - 1071-3581

VL - 22

SP - 372

EP - 380

JO - Journal of Nuclear Cardiology

JF - Journal of Nuclear Cardiology

IS - 2

ER -